[Corrigendum] miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression

Wen,Xueyan; Li,Songrong; Guo,Mengchan; Liao,Hongzhan; Chen,Yongmin; Kuang,Xi; Liao,Xiaoping; Ma,Lin; Li,Qifu

doi:10.3892/ol.2025.14965

May-2025 Volume 29 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2025 Volume 29 Issue 5

Full Size Image

Correction Open Access

[Corrigendum] miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression

Authors:
- Xueyan Wen
- Songrong Li
- Mengchan Guo
- Hongzhan Liao
- Yongmin Chen
- Xi Kuang
- Xiaoping Liao
- Lin Ma
- Qifu Li
View Affiliations / Copyright

Affiliations: Department of Neurology, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570102, P.R. China

Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 219
|
Published online on: March 5, 2025

https://doi.org/10.3892/ol.2025.14965
Expand metrics +

Article

Oncol Lett 20: [Related article:] 235, 2020; DOI: 10.3892/ol.2020.12098

Following the publication of the above article, an interested reader drew to the authors’ attention that the western blot data (both the control GAPDH and the FBXO11 protein bands) in Fig. 3C on p. 6 were strikingly similar to data which had previously appeared in an article published in the journal Oncotarget, albeit one of the authors (Hongzhan Liao) was featured as an author on both papers. After having re-examined their original data, the authors realized that the wrong data had inadvertently been included in this figure part.

Figure 3.

miR-181a-5p targeting FBXO11. (A) Map of FBXO11 and miR-181a-5p target sites. In the 3’-UTR FBXO11 non-coding region. The luciferase activity of U251 cells co-transfected with miR-181a-5p mimic and wt FBXO11 3’-UTR was lower compared with that of NC cells in FBXO11-wt group. *P<0.05. (B) The left panel shows the expression of FBXO11 mRNA in glioma and drug-resistant cell lines. The right panel shows that upregulation miR-181a-5p inhibits the expression levels of FBXO11 mRNA in glioma-resistant cells. *P<0.05. (C and D) Western blot assays were performed to determine (C) FBXO11 expression in normal glioma cells and drug-resistant glioma cells, and (D) miR-181A-5P targeting FBXO11. FBXO11 expression was downregulated in drug-resistant glioma cells transfected with miR-181a-5p mimic. FBXO11 expression was upregulated in glioma cells transfected with miR-181a-5p inhibitor. ***P<0.001. miR, microRNA; UTR, untranslated region; FBXO11, F-Box protein 11; NC, negative control; wt, wild-type.

The revised version of Fig. 4, now featuring the correct data for the GAPDH and the FBXO11 experiments in Fig. 3C, is shown on the next page. Note that the errors made in assembling this figure did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this. The authors also apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression

This article is mentioned in:

Article

Figure 3.

Related Articles